检索结果 - Idbaih, A

Glioblastoma targeted therapy: updated approaches from recent biological insights 由 Touat, M., Idbaih, A., Sanson, M., Ligon, K. L.

获取全文 获取全文 获取全文

P04.10 Chains of magnetosomes induce full destruction of intracranial U87-Luc and subcutaneous GL-261 glioma in mice under the application of an alternating magnetic field 由 Alphandery, E, Idbaih, A, Adam, C, Delattre, J, Schmitt, C, Guyot, F, Chebbi, I

获取全文 获取全文

P04.14 IDH1 MUTATION IN LOW-GRADE GLIOMAS RELATED TO EPILEPSY AS INITIAL SYMPTOM 由 Duran-Peña, A., Mokhtari, K., Marie, Y., Alentorn, A., Delattre, J., Idbaih, A., Sanson, M., Vecht, C.

获取全文 获取全文

P17.08 RENAL THROMBOTIC MICROANGIOPATHY INDUCED BY BEVACIZUMAB IN HIGH GRADE GLIOMA PATIENTS - ABOUT SIX CASES 由 Blonski, M., Simon, L., Houillier, C., Idbaih, A., Wittwer, B., Beauchesne, P., Hoang-Xuan, K., Taillandier, L.

获取全文 获取全文

P10.14 Long-term impact of Temozolomide on 1p19q codeleted oligodendrogliomas growth kinetics 由 Izquierdo, C., Alentorn, A., Simó, M., Idbaih, A., Ricard, D., Kaloshi, G., Bruna, J., Honnorat, J., Delattre, J., Ducray, F.

获取全文 获取全文

OS5.5 Characteristics of high-grade gliomas with H3 G34 mutation in adults 由 Picart, T, Barritault, M, Tabouret, E, Idbaih, A, Izquierdo Gracia, C, Poncet, D, Honnorat, J, Meyronet, D, Guyotat, J, Ducray, F

获取全文 获取全文

P05.05 Safety and feasibility of temporary blood-brain barrier disruption with the SonoCloud-1/3 implantable ultrasound device in recurrent glioblastoma 由 Idbaih, A, Canney, M, Bouchoux, G, Desseaux, C, Vignot, A, Lafon, C, Chapelon, J, Delattre, J, Belin, L, Carpentier, A

获取全文 获取全文

OS11.3 Machine learning for better prognostic stratification and driver genes identification in 1p/19q-codeleted grade III gliomas 由 Rosenberg, S., Dehais, C., Ducray, F., Alentron, A., Tanguy, M., De Reyneis, A., Elarouci, N., Figarella-Branger, D., Delattre, J., Idbaih, A.

获取全文 获取全文

EH1.3 EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine versus lomustine in patients with first progression of a glioblastoma 由 van den Bent, M., Gorlia, T., Bendszus, M., Sahm, F., Domont, J., Idbaih, A., Platten, M., Weller, M., Golfoinopoulos, V., Wick, W.

获取全文 获取全文

P01.148 Intra-tumor heterogeneity analysis of low-grade gliomas. A POLA Network study 由 Alentorn, A, Labreche, K, Dehais, C, Carpentier, C, Ducray, F, Mokhtari, K, Figarella-Branger, D, Sanson, M, Delattre, J, Idbaih, A

获取全文 获取全文

P06.18 DNA methylation distance score in lower-grade gliomas has prognostic value: a POLA network study 由 Alentorn, A., Kamoun, A., Ducray, F., Dehais, C., Mokhtari, K., Uro-Coste, E., Figarella-Branger, D., Delattre, J., Idbaih, A., Sanson, M.

获取全文 获取全文

P06.19 TERT promoter mutation is an independent prognostic factor in 1p/19q co-deleted oligodendrogliomas: a POLA network study 由 Alentorn, A., Carpentier, C., Labreche, K., Ducray, F., Dehais, C., Mokhtari, K., Uro-Coste, E., Figarella-Branger, D., Delattre, J., Idbaih, A.

获取全文 获取全文

O10.02 MITOTIC INDEX, MICROVASCULAR PROLIFERATION AND NECROSIS DEFINE THREE GROUPS OF 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS ASSOCIATED WITH DIFFERENT GENOMIC ALTERATIONS 由 Figarella-Branger, D., Mokhtari, K., Dehais, C., Jouvet, A., Uro-Coste, E., Colin, C., Carpentier, C., Ducray, F., Idbaih, A., Network, French POLA

获取全文 获取全文

P09.14 Clonal and subclonal evolution of 1p/19q co-deleted oligodendrogliomas 由 Alentorn, A., Daniau, M., Royer-Perron, L., Labreche, K., Duran-Pena, A., Marie, Y., Hoang-Xuan, K., Sanson, M., Delattre, J., Idbaih, A.

获取全文 获取全文

P20.01 MEVITEM: A European, randomized, open-label Phase I/II study of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent or ref... 由 Frappaz, D., Meyronnet, D., Garin, G., Laigle-Donadey, F., Le Rhun, E., Bonneville-Levard, A., Frenel, J., Idbaih, A., Gourmelon, C., Chinot, O.

获取全文 获取全文

P11.59 Integrin a5 heterogeneous expression in glioblastoma is related to glioma stem cell subpopulations 由 Dontenwill, M, Mercier, M, Gillmann, G, Reita, D, Lelong-Rebel, I, Noulet, F, Idbaih, A, Herold-Mende, C, Bagnard, D, Spenlé, C, Martin, S

获取全文 获取全文

OS8.5 How to assess meningioma therapy activity: The CEVOREM independent central review experience 由 GRAILLON, T, Colin, T, Peyrière, H, Peyre, M, Tabouret, E, Campello, C, Idbaih, A, Boucekine, M, Figarella-Branger, D, Kalamarides, M, Dufour, H, Sanson, M, Chinot, O

获取全文 获取全文

P17.01 CHROMOSOME ARM 9P LOSS OF HETEROZYGOSITY IS A MARKER OF SHORTER SURVIVAL IN 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA. A POLA NETWORK STUDY 由 Alentorn, A., Dehais, C., Carpentier, C., Mokhtari, K., Ducray, F., Figarella-Branger, D., Delattre, J., Idbaih, A., (POLA)”, POLA Network “Prise en charge des OLigodendrogliomes Anaplasiques

获取全文 获取全文

OS5.2 Health-Related Quality of Life (HRQoL) in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only (randomized phase III E... 由 Taphoorn, M. J. B., Bottomley, A., Coens, C., Reijneveld, J. C., Gorlia, T., Brandes, A. A., Domont, J., Idbaih, A., van den Bent, M. J., Wick, W.

获取全文 获取全文

OS5.7 First results of the randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact 1st recurrence grade II and III glioma 由 Idbaih, A., Clement, P. M., Vos, F. Y. F., Platten, M., Mulholland, P., Taphoorn, M. J. B., Lewis, L., Golfinopoulos, V., Gorlia, T., van den Bent, M. J.

获取全文 获取全文